Följ
Chris Skedgel
Chris Skedgel
Office of Health Economics
Verifierad e-postadress på ohe.org - Startsida
Titel
Citeras av
Citeras av
År
Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial
DR Anderson, SR Kahn, MA Rodger, MJ Kovacs, T Morris, A Hirsch, ...
Jama 298 (23), 2743-2753, 2007
7112007
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
MG Brown, S Kirby, C Skedgel, JD Fisk, TJ Murray, V Bhan, IS Sketris
Neurology 69 (15), 1498-1507, 2007
1002007
Considerations and costs of disclosing study findings to research participants
CV Fernandez, C Skedgel, C Weijer
Cmaj 170 (9), 1417-1419, 2004
932004
Hospital-based psychiatric service utilization and morbidity in multiple sclerosis
JD Fisk, SA Morehouse, MG Brown, C Skedgel, TJ Murray
Canadian journal of neurological sciences 25 (3), 230-235, 1998
721998
An incremental cost analysis of telehealth in Nova Scotia from a societal perspective
DD Persaud, S Jreige, C Skedgel, J Finley, J Sargeant, N Hanlon
Journal of Telemedicine and Telecare 11 (2), 77-84, 2005
692005
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
NWD Lamond, C Skedgel, D Rayson, L Lethbridge, T Younis
Breast cancer research and treatment 133, 1115-1123, 2012
632012
Gout in the elderly—a population health study
JG Hanly, C Skedgel, I Sketris, C Cooke, T Linehan, K Thompson, ...
The Journal of Rheumatology 36 (4), 822-830, 2009
622009
Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment
C Skedgel, A Wailoo, R Akehurst
Medical Decision Making 35 (1), 94-105, 2015
602015
The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada
A Drucker, C Skedgel, K Virik, D Rayson, M Sellon, T Younis
Current oncology 15 (3), 136-142, 2008
562008
The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use
KK Dhatariya, C Skedgel, R Fordham
Diabetic Medicine 34 (10), 1361-1366, 2017
542017
Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital
HL Neville, B Chevalier, C Daley, L Nodwell, C Harding, A Hiltz, ...
International Journal of Pharmacy Practice 22 (3), 216-222, 2014
542014
Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression: first estimates
MG Brown, TJ Murray, IS Sketris, JD Fisk, JC LeBlanc, CE Schwartz, ...
International Journal of Technology Assessment in Health Care 16 (03), 751-767, 2000
532000
The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of …
C Skedgel, D Wranik, M Hu
Pharmacoeconomics 36, 467-475, 2018
472018
The cost‐utility of sequential adjuvant trastuzumab in women with Her2/Neu‐positive breast cancer: An analysis based on updated results from the HERA Trial
C Skedgel, D Rayson, T Younis
Value in Health 12 (5), 641-648, 2009
442009
The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty
C Skedgel, R Goeree, S Pleasance, K Thompson, B O'brien, D Anderson
JBJS 89 (4), 819-828, 2007
442007
Choosing vs. allocating: discrete choice experiments and constant‐sum paired comparisons for the elicitation of societal preferences
CD Skedgel, AJ Wailoo, RL Akehurst
Health Expectations 18 (5), 1227-1240, 2015
422015
Simultaneous liver kidney transplantation: a medical decision analysis
B Kiberd, C Skedgel, I Alwayn, K Peltekian
Transplantation 91 (1), 121-127, 2011
392011
Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole
C Skedgel, D Rayson, R Dewar, T Younis
Breast cancer research and treatment 101, 325-333, 2007
382007
Identification of patients with systemic lupus erythematosus in administrative healthcare databases
JG Hanly, K Thompson, C Skedgel
Lupus 23 (13), 1377-1382, 2014
362014
The cost–utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer
T Younis, D Rayson, C Skedgel
Current Oncology 18 (6), 288-296, 2011
362011
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20